Mount Sinai's Dr. Mary Ann McLaughlin discusses medications for heart disease, such as cholesterol-lowering drugs, low-dose aspirin and beta blockers and how they benefit patients.Dr. McLaughlin is the recipient of grants from the Agency for Health Care Quality and Research, the American Heart Association, the American College of Cardiology, and the New York Academy of Medicine. Her research focuses on improving the cardiovascular care of women, elderly and minorities. She has published numerous articles in peer-reviewed journals, and is the author of four book chapters, and is on the Editorial board of the publication, "Focus on Healthy Aging." She has been an invited speaker both nationally and internationally.
